Neurovascular Catheters Market Report 2026

Neurovascular Catheters Market Overview

• Neurovascular Catheters market size has reached to $4.87 billion in 2025 • Expected to grow to $8.17 billion in 2030 at a compound annual growth rate (CAGR) of 11% • Growth Driver: Surge In Aging Population Fueling The Growth Of The Market Due To Increased Prevalence Of Neurological Disorders • Market Trend: Innovations In Balloon Guide Catheter Technology Enhance Neurovascular Intervention Capabilities • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neurovascular Catheters Market?

Neurovascular catheters are medical devices used to treat neurological issues and diseases by providing access to neurovascular organs and the delivery of embolic coils and thrombectomy devices. They are used in minimally invasive therapies to treat blood vessel disorders in the brain, where catheters are manually inserted into the patient's femoral or brachial arteries and guided to the brain to provide treatment that eliminates cutting into the patient's skull and brain tissue. The main types of neurovascular catheters are micro catheters, balloon catheters, access catheters, embolization catheters, and others. Micro catheters are small 0.70-1.30mm diameter catheters used in complex endovascular operations for guidewire support, exchanges, accessing distal anatomy, crossing lesions, delivering therapeutic embolic, injecting contrast media, and performing other procedures and other minimally invasive procedures to deliver gadgets and navigate the human body's complicated vasculature. The major applications are embolic stroke, brain aneurysm, arteriovenous malformations, and others that are used in hospitals, clinics, ambulatory surgical centers, and diagnostic centers.

What Is The Neurovascular Catheters Market Growth Forecast?

The neurovascular catheters market size is expected to see rapid growth in the next few years. It will grow to $8.17 billion in 2030 at a compound annual growth rate (CAGR) of 11.0%. The growth in the forecast period can be attributed to increasing demand for thrombectomy procedures, rising aging population with cerebrovascular risks, growing investments in neurointerventional technologies, expansion of advanced imaging-assisted interventions, increasing preference for minimally invasive brain therapies. Major trends in the forecast period include increasing adoption of steerable micro catheters, rising use of minimally invasive neurovascular procedures, growing demand for advanced embolization catheters, expansion of image-guided catheter navigation, enhanced focus on device flexibility and precision.

What Is The Driver Of The Neurovascular Catheters Market?

The rising aging population is expected to propel the growth of the neurovascular catheter market going forward. An aging population refers to a demographic shift characterized by an increasing proportion of elderly individuals within a society over time. Neurovascular catheters play a crucial role in the aging population by addressing various neurological conditions that become more prevalent as individuals age. For instance, in January 2024, according to the Population Reference Bureau, a US-based nonprofit organization specializing in collecting and supplying statistics, the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase), and the 65-and-older age group’s share of the total population is projected to rise from 17% to 23%. Therefore, the rising ageing population is driving the neurovascular catheter industry.

Key Players In The Global Neurovascular Catheters Market

Major companies operating in the neurovascular catheters market are Medtronic plc, Stryker Corporation, Penumbra Inc., Johnson & Johnson, Terumo Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, Concentric Medical Inc., Raumedic AG, Olympus Corporation, B. Braun Melsungen AG, Imperative Care Inc., Balt LLC, Phenox GmbH, Teleflex Incorporated, MicroVention Inc., Boston Scientific Corporation, Cook Medical LLC, Cordis Corporation, Merit Medical Systems Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Abbott Laboratories

Global Neurovascular Catheters Market Trends and Insights

Major companies operating in the neurovascular catheter market are focusing on developing advanced solutions, such as balloon guide catheters (BGCs), to enhance procedural support, distal navigation, and treatment precision in neurovascular interventions. A balloon guide catheter is a medical device used in interventional neuroradiology and neurointerventional surgery to facilitate safe and effective treatment of cerebrovascular conditions, including stroke. For instance, in March 2023, Q’Apel Medical Inc., a US-based neurovascular device company, received CE Mark approval for its Walrus Balloon Guide Catheter (BGC). Designed with a 0.087″ inner diameter, the device provides improved proximal stability, distal trackability, and compatibility with complex stroke interventions, supporting better procedural outcomes and clinical decision-making. Q’Apel Medical specializes in high-precision neurovascular devices aimed at advancing interventional treatment options.

What Are Latest Mergers And Acquisitions In The Neurovascular Catheters Market?

In October 2023, Integer Holdings Corporation, a US-based contract development and manufacturing organization (CDMO), acquired substantially all of the assets of InNeuroCo, Inc. for $ 44.5 million. Through this acquisition, Integer aims to enhance its neurovascular catheter capabilities by integrating InNeuroCo’s differentiated designs and advanced manufacturing technologies, expanding its portfolio of solutions for stroke and intracranial aneurysm treatments. InNeuroCo Inc. is a US-based company specializing in complex neurovascular catheters, including access guide catheter designs, prototype-to-volume manufacturing, and novel delivery systems.

What Defines the Neurovascular Catheters Market?

The neurovascular catheters market consists of sales of occlusion catheters, stent delivery catheters, diagnostic catheters, guiding catheters, and distal access catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neurovascular Catheters Market Report 2026?

The neurovascular catheters market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurovascular catheters industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.